Patents by Inventor Andrew J. Morris

Andrew J. Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11941160
    Abstract: A method includes transmitting an instruction to a motive power supply of an elastically deformable device to drive the elastically deformable device in accordance with a drive setting; measuring a force exerted on the elastically deformable device with a sensor; outputting an observed value representative of the force; comparing the observed value with a reference value corresponding with a predetermined force to be exerted on the elastically deformable device; and adjusting the drive setting based on a determination that the observed value is outside of a predetermined range of the reference value. The method prevents slack in the elastically deformable device over time. Related apparatuses, systems, techniques and articles are also described.
    Type: Grant
    Filed: February 17, 2023
    Date of Patent: March 26, 2024
    Assignee: Baker Hughes Oilfield Operations LLC
    Inventors: Andrew Lee Tang, Bryan Christopher Morris, James J. Delmonico
  • Publication number: 20030124108
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmacuetical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Application
    Filed: April 30, 2002
    Publication date: July 3, 2003
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht
  • Patent number: 6379665
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmaceutical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: April 30, 2002
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht
  • Patent number: 6043073
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmacuetical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: March 28, 2000
    Assignee: The Research Foundation of the State University of New York
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht